A breakthrough in lymphoma therapy

Bartosz Puła

Vol 55, No 4 (2024)

Editorial

Bispecific antibodies in relapsed/refractory diffuse large B-cell lymphoma.

Michał Danecki, Wojciech Jurczak

Vol 55, No 4 (2024)

Review article

Therapy-related myeloid malignancies in patients with multiple myeloma.

Tadeusz Kubicki, Monika Adamska, Krzysztof Żyłka, Dominik Dytfeld, Lidia Gil

Vol 55, No 4 (2024)

Review article

Tabelecleucel: a new therapeutic option in refractory EBV-PTLD

Jan Styczyński, Monika Pogorzała, Jagoda Sadlok, Magdalena Woźniak

Vol 55, No 4 (2024)

Review article

Nicotine addiction and an elevated cholesterol level exhibit negative effects on platelet activation in patients with chronic Buerger’s disease

Aleksandra Nowaczyńska, Tomasz Zubilewicz, Bożena Sokołowska, Piotr Terlecki, Agnieszka Szymczyk, Iwona Hus

Vol 55, No 4 (2024)

Original research article

Ischemic stroke as a consequence of acute hemolytic anemia following arsenic poisoning.

Malgorzata Elżbieta Poniatowska, Izabela Molka, Tomasz Janus, Barbara Potocka-Banaś, Krzysztof Kowalik, Marta Niewiadomska, Justyna Jabłońska-Odroniec, Katarzyna Brzeźnikiewicz-Janus

Vol 55, No 4 (2024)

Clinical vignette

Toxic epidermal necrolysis after allogeneic hematopoietic stem cell transplantation for refractory Hodgkin’s lymphoma.

Karolina Chromik, Aleksandra Spyra, Paulina Repa, Grzegorz Helbig

Vol 55, No 4 (2024)

Clinical vignette

Effective treatment of autoimmune thrombocytopenia with rituximab in CLL patient undergoing therapy with acalabrutinib

Elżbieta Iskierka-Jażdżewska, Tadeusz Robak

Vol 55, No 4 (2024)

Clinical vignette

Acute intermittent porphyria: a diagnostic challenge.

Karol Bigosiński, Maciej Dubaj, Aneta Szudy-Szczyrek, Marek Hus

Vol 55, No 4 (2024)

Clinical vignette